This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Mednow Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	keine Daten

Jüngste Management Updates

Recent updates

Is Mednow (CVE:MNOW) In A Good Position To Deliver On Growth Plans?

Jun 24

We're Hopeful That Mednow (CVE:MNOW) Will Use Its Cash Wisely

Mar 11

Geschäftsführer

Mednow hat keinen Geschäftsführer, oder es liegen keine verfügbaren Daten vor.

This company listing is no longer active

Mednow Management

Management Kriterienprüfungen 0/4

Wichtige Informationen

Jüngste Management Updates

Mednow Announces Executive Changes

Mednow Announces Board Member Resignations

Mednow Inc. Announces CEO Changes

Mednow Inc., Annual General Meeting, Jun 07, 2022

Mednow Inc. Appoints Carey Lai as Director of Pharmacy Operations

Recent updates

Mednow Announces Notice Received from Secured Creditor

Mednow Announces Notice Received from Secured Creditor

Mednow Announces Executive Changes

Mednow Inc. announced that it has received CAD 0.85 million in funding

Mednow Inc. Announces the Execution of Cost Reductions Through the Wind-Down of A Subsidiary

Mednow Inc. Announces the Execution of Cost Reductions Through the Wind-Down of A Subsidiary

Mednow Announces Board Member Resignations

Mednow Inc. announced that it has received CAD 0.4 million in funding

Mednow Inc. announced that it expects to receive CAD 0.4 million in funding

Third quarter 2023 earnings released: CA$0.19 loss per share (vs CA$0.26 loss in 3Q 2022)

Mednow Inc. announced that it expects to receive CAD 0.585 million in funding

Mednow Inc. has completed a Composite Units Offering in the amount of CAD 0.525262 million.

Second quarter 2023 earnings released: CA$0.20 loss per share (vs CA$0.26 loss in 2Q 2022)

Mednow Inc. Supports Expanded Scope of Practice for Ontario Pharmacists

First quarter 2023 earnings released

Mednow Inc. Expands Suite of Services

Full year 2022 earnings released: CA$1.37 loss per share (vs CA$0.49 loss in FY 2021)

Mednow Inc. Announces CEO Changes

Third quarter 2022 earnings released

Mednow Inc. Provides Earnings Guidance for the Third Quarter of Fiscal Year Ending April 30, 2022

Mednow Inc., Annual General Meeting, Jun 07, 2022

Mednow Inc. (TSXV:MNOW) completed the acquisition of Mednow East Inc. from Amir Ali Reyhany-Bozorg, Felipe Campusano and Karim Nassar and others.

Mednow Inc. Provides Earnings Guidance for the Years of 2022 and 2023

Mednow Inc. (TSXV:MNOW) completed the acquisition of Liver Care Canada Inc.

Mednow Inc. (TSXV:MNOW) entered into a share purchase agreement to acquire London Pharmacare Inc. from Felipe Campusano and others for CAD 0.59 million.

Mednow Inc. (TSXV:MNOW) entered into an agreement to acquire Liver Care Canada Inc. for CAD 0.07 million.

Mednow Inc. (TSXV:MNOW) completed the acquisition of Infusicare Canada Inc. from Amir Ali Reyany-Bozorg, Felipe Campusano and others for CAD 1.9 million.

Mednow Inc. (TSXV:MNOW) entered into a share purchase agreement to acquire Mednow Pharmacy Inc. from Amir Ali Reyhany-Bozorg, Karim Nassar and Felipe Campusano for CAD 0.074 million.

Mednow Inc. (TSXV:MNOW) acquired 2716725 Ontario Inc. for CAD 2 million.

Is Mednow (CVE:MNOW) In A Good Position To Deliver On Growth Plans?

Chief Financial Officer Joshua Lebovic has left the company

Mednow Inc. Appoints Carey Lai as Director of Pharmacy Operations

We're Hopeful That Mednow (CVE:MNOW) Will Use Its Cash Wisely

Geschäftsführer